ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,324 | -12.7% | 111,534 | +0.3% | 0.11% | -6.0% |
| Q2 2023 | $2,662 | -0.2% | 111,154 | -21.5% | 0.12% | -7.9% |
| Q1 2023 | $2,666 | -4.0% | 141,664 | -18.8% | 0.13% | -18.2% |
| Q4 2022 | $2,778 | -99.9% | 174,519 | -1.8% | 0.15% | -12.5% |
| Q3 2022 | $2,907,000 | +24.2% | 177,712 | +7.0% | 0.18% | 0.0% |
| Q2 2022 | $2,341,000 | -7.1% | 166,131 | +59.7% | 0.18% | +6.7% |
| Q1 2022 | $2,520,000 | +196.5% | 104,052 | +185.6% | 0.16% | +55.7% |
| Q4 2021 | $850,000 | +155.3% | 36,432 | +81.6% | 0.11% | +140.9% |
| Q3 2021 | $333,000 | -9.8% | 20,062 | +190.9% | 0.04% | -58.1% |
| Q4 2020 | $369,000 | +29.5% | 6,897 | 0.0% | 0.10% | +16.7% |
| Q3 2020 | $285,000 | -50.8% | 6,897 | -42.2% | 0.09% | -54.3% |
| Q2 2020 | $579,000 | -41.9% | 11,937 | -49.4% | 0.20% | -53.1% |
| Q1 2020 | $997,000 | +276.2% | 23,609 | +220.3% | 0.42% | +324.2% |
| Q3 2019 | $265,000 | – | 7,370 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |